Literature DB >> 17389334

Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes.

Hirofumi Makino1, Masakazu Haneda, Tetsuya Babazono, Tatsumi Moriya, Sadayoshi Ito, Yasuhiko Iwamoto, Ryuzo Kawamori, Masahiro Takeuchi, Shigehiro Katayama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17389334     DOI： 10.2337/dc06-1998

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  69 in total

Review 1.  Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.

Authors:  Raimund H Pichler; Ian H de Boer
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

Review 2.  Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease.

Authors:  Ravi Nistala; Yongzhong Wei; James R Sowers; Adam Whaley-Connell
Journal:  Transl Res       Date:  2009-01-23       Impact factor: 7.012

Review 3.  Treating to protect: current cardiovascular treatment approaches and remaining needs.

Authors:  Michael Böhm; Christian Werner; Anne Jakobsen; Jose Heroys; Ann Ralph; Tomas Rees; Michael Shaw
Journal:  Medscape J Med       Date:  2008-03-26

4.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

Review 5.  [Diabetic kidney disease - Update 2016].

Authors:  Harald Sourij; Roland Edlinger; Friedrich Prischl; Martin Auinger; Alexandra Kautzky-Willer; Marcus D Säemann; Rudolf Prager; Martin Clodi; Guntram Schernthaner; Gert Mayer; Rainer Oberbauer; Alexander R Rosenkranz
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

6.  Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease.

Authors:  Tobias F Kröpelin; Dick de Zeeuw; Giuseppe Remuzzi; Rudy Bilous; Hans-Henrik Parving; Hiddo J L Heerspink
Journal:  J Am Soc Nephrol       Date:  2016-04-07       Impact factor: 10.121

Review 7.  Clinical therapeutic strategies for early stage of diabetic kidney disease.

Authors:  Munehiro Kitada; Keizo Kanasaki; Daisuke Koya
Journal:  World J Diabetes       Date:  2014-06-15

Review 8.  New standards in hypertension and cardiovascular risk management: focus on telmisartan.

Authors:  Domenico Galzerano; Cristina Capogrosso; Sara Di Michele; Antonio Galzerano; Paola Paparello; Diana Lama; Carlo Gaudio
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

Review 9.  Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.

Authors:  Prasad Bichu; Ravi Nistala; Asma Khan; James R Sowers; Adam Whaley-Connell
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

Review 10.  Cardiovascular disease in patients with chronic kidney disease.

Authors:  Julian Wright; Alastair Hutchison
Journal:  Vasc Health Risk Manag       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.